Latest news
AQUAPASS Completes Enrollment in REFORM-HF Pivotal Trial, Results to Be Presented at Major Heart Failure Conference This Fall - PR NewswirePR Newswire · Mon, 10 Aug 2026 13:40:00 GMTTirzepatide lowers heart attack and cardiovascular event risk in adults with type 2 diabetes - News-MedicalNews-Medical · Mon, 10 Aug 2026 06:17:00 GMTScientists reveal how much exercise you really need to protect your heart - ScienceDailyScienceDaily · Thu, 06 Aug 2026 07:00:00 GMTGLP-1 drug tirzepatide associated with lower risk of major cardiovascular events - News-MedicalNews-Medical · Thu, 06 Aug 2026 03:56:00 GMTNew therapy may reduce HF risk after heart attack - healthcare-in-europe.comhealthcare-in-europe.com · Sun, 02 Aug 2026 06:04:04 GMTGene-regulation map reveals treatment targets for heart failure - The University of UtahThe University of Utah · Tue, 28 Jul 2026 07:00:00 GMT